Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

Background: Out-of-pocket costs pose a substantial economic burden to cancer patients and
their families. The purpose of this study was to evaluate the literature on out-of-pocket costs …

Chimeric antigen receptor (CAR) T cell therapy is changing the paradigm in hematologic
malignancies, but disparities in access exist in the real-world setting. Efforts to address and …

Clinical trials are imperative for testing novel cancer therapies, advancing the science of
cancer care, and determining the best treatment strategies to enhance outcomes for patients …

Importance Financial toxicity (FT), unintended and unanticipated financial burden
experienced by cancer patients undergoing cancer care, is associated with negative …

Molecular and immune therapies have revolutionized cancer treatment and improved
patient outcomes and survival. However, the pricing of these drugs has become an issue as …

Background Cancer survivors frequently experience medical financial hardship in the United
States. Little is known, however, about long-term health consequences. This study examines …

Cancer survivors spend more out of pocket (OOP) for medical care than their counterparts
without a cancer history, a pattern that persists many years after cancer diagnosis and …

Purpose Financial toxicity after breast cancer may be exacerbated by adverse treatment
effects, like breast cancer-related lymphedema. As the first study of long-term out-of-pocket …

To date, knowledge of the experiences of older adults' caregivers at the end of life has come
from studies that were limited to specific diseases and so-called primary caregivers and that …